Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01

European Journal of Cancer

Volumn 48, Issue 17, 2012, Pages 3240-3248

  Graf, Norbert ^a   Van Tinteren, Harm ^b   Bergeron, Christophe ^c   Pein, François ^d   Van Den Heuvel Eibrink, Marry M ^e   Sandstedt, Bengt ^f   Schenk, Jens Peter ^g   Godzinski, Jan ^h   Oldenburger, Foppe ⁱ   Furtwängler, Rhoikos ^a   De Kraker, Jan ^j  

^a SAARLAND UNIVERSITY   (Germany)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c Institut d'Hemato Oncologie Pediatrique   (France)

^d Service de Pédiatrie   (France)

^e SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^f KAROLINSKA INSTITUTE   (Sweden)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h T Marciniak Lower Silesia Specialist Hospital Wroclaw   (Poland)

ⁱ ACADEMIC MEDICAL CENTER   (Netherlands)

^j EMMA CHILDREN S HOSPITAL   (Netherlands)

more..

Author keywords

Local stage II and III; Neoadjuvant treatment; Prognosis; Wilms tumour

Indexed keywords

DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG FATALITY; EVENT FREE SURVIVAL; FEMALE; HUMAN; IRRADIATION; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEPHROBLASTOMA; OVERALL SURVIVAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RHABDOMYOSARCOMA; TREATMENT OUTCOME; TUMOR VOLUME;

ADOLESCENT; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; NEOPLASM STAGING; PROGNOSIS; TREATMENT OUTCOME; TUMOR BURDEN; WILMS TUMOR;

EID: 84868210723     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.06.007     Document Type: Article

References (32)

1. N. Graf, M.F. Tournade, and J. de Kraker The role of preoperative chemotherapy in the management of Wilms' tumor. The SIOP studies Urol Clin North Am 27 2000 443 450
2. H.L. Neville, and M.L. Ritchey Wilms' tumor: overview of National Wilms' Tumor Study Group results Urol Clin North Am 27 2000 435 442
3. J.A. Kalapurakal, J.S. Dome, and E.J. Perlman Management of Wilms' tumour: current practice and future goals Lancet Oncol 5 2004 37 46
4. M.F. Tournade, C. Com-Nougué, and P.A. Voûte Results of the Sixth International Society of Pediatric Oncology 6 Wilms' tumor trial and study: a risk-adapted therapeutic approach in Wilms' tumor J Clin Oncol 11 1993 1014 1023
5. M.F. Tournade, C. Com-Nougué, and J. de Kraker Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study J Clin Oncol 19 2001 488 500
6. J. De Kraker, N. Graf, and H. van Tinteren Reduction of postoperative chemotherapy in children with stage I intermediate risk and anaplasia Wilms' tumour. The SIOP 93-01 randomised trial Lancet 364 2004 1229 1235
7. J.F. Delemarre, B. Sandstedt, and D. Harms The new SIOP (Stockholm) working classification of renal tumours of childhood. Int Soc Paediatric Oncol Med Pediatr Oncol 26 1996 145 146
8. L.A. Boccon-Gibod Pathological evaluation of renal tumors in children: International Society of Pediatric Oncology approach Pediatr Dev Pathol 1 1998 243 248
9. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
10. G.J. D'Angio, A.E. Evans, and N. Breslow The treatment of Wilms' tumour: results of the National Wilms' Tumour Study Cancer 38 1976 633 646
11. G.J. D'Angio, A.E. Evans, and N. Breslow The treatment of Wilms' Tumour: results of the second National Wilms' Tumour Study Cancer 47 1981 2303 2311
12. D.M. Green, N.E. Breslow, and J.B. Beckwith Effect of duration of treatment on outcome and cost of treatment for Wilms' tumour: a report from the National Wilms' Tumour Study Group J Clin Oncol 16 1998 3744 3751
13. D.M. Green, N.E. Breslow, and J.B. Beckwith Treatment with nephrectomy only for small, stage I/favourable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group J Clin Oncol 19 2001 3719 3724
14. P.E. Grundy, N.E. Breslow, and S. Li Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group J Clin Oncol 23 2005 7312 7321
15. C. Mitchell, P. Morris Jones, and A. Kelsey The treatment of Wilms' tumour: results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study Br J Cancer 83 2000 602 608
16. R.G. Grundy, C. Hutton, and H. Middleton Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study Pediatr Blood Cancer 42 2004 311 319
17. C. Mitchell, K. Pritchard-Jones, and R. Shannon Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group Eur J Cancer 42 2006 2554 2562
18. A. Weirich, I. Leuschner, and D. Harms Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH Ann Oncol 12 2001 311 319
19. N. Breslow, K. Sharples, and J.B. Beckwith Prognostic factors in nonmetastatic, favorable histology Wilms' tumor. Results of the third National Wilms' Tumor Study Cancer 68 1991 2345 2353
20. A.C. Verschuur, G.M. Vujanic, and H. Van Tinteren Stromal and epithelial predominant Wilms tumours have an excellent outcome: the SIOP 93 01 experience Pediatr Blood Cancer 55 2010 233 238
21. H. Reinhard, O. Semler, and D. Bürger Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms, Tumor Klin Padiatr 216 2004 132 140
22. R.C. Shamberger, J.R. Anderson, and N.E. Breslow Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5 Ann Surg 251 2010 555 558
23. D.M. Green, N.E. Breslow, and J.B. Beckwith Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: a report from the National Wilms' Tumor Study J Clin Oncol 11 1993 91 95
24. A. Pession, E. Dama, and R. Rondelli Survival of children with cancer in Italy, 1989-98. A report from the hospital based registry of the Italian Association of Paediatric Haematology and Oncology (AIEOP) EJC 44 2008 1282 1289
25. P.D. Angelo, A.D. Cataldo, and M. Bianchi Why Wilms' tumour diagnosed in children <24 months of age have a better prognosis? An evaluation from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) WT working group Pediatr Blood Cancer 55 2010 842 (0199)
26. M. Marx, T. Langer, and N. Graf Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No. 9/GPOH and SIOP 93-01/GPOH Med Pediatr Oncol 39 2002 18 24
27. D.M. Green, Y.A. Grigoriev, and B. Nan Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group J Clin Oncol 19 2001 1926 1934
28. N.E. Breslow, S.S. Ou, and J.B. Beckwith Doxorubicin for favorable histology, stage II-III Wilms tumor: results from the National Wilms Tumor Studies Cancer 101 2004 1072 1080
29. C.C. Huang, S. Gadd, and N. Breslow Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group Clin Cancer Res 15 2009 1770 1778
30. S.C. Kaste, J.S. Dome, and P.S. Babyn Wilms tumour: prognostic factors, staging, therapy and late effects Pediatr Radiol 38 2008 2 17
31. N. Graf, A. Hoppe, and E. Georgiadi 'In silico' oncology for clinical decision making in the context of nephroblastoma Klin Padiatr 221 2009 141 149
32. p-medicine: From data sharing and integration via VPH models to personalized medicine. Large Scale Integrating Project. FP/-ICT-2009-6. Grant Agreement No.: 270089. [last visit: 1st July 2012].